SCHEMBL7367690

SCHEMBL7367690

COc1cc(C(=O)c2ccccc2F)ccc1O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 1/20 0.66
SLC22A8 Q8TCC7 1/20 0.66
KMT2A Q03164 4/20 0.57
MEN1 O00255 3/20 0.57
RAB9A P51151 2/20 0.57
HTT P42858 2/20 0.55
POLB P06746 2/20 0.55
MAPT P10636 5/20 0.52
CYP3A4 P08684 3/20 0.52
KDM4E B2RXH2 3/20 0.52
LMNA P02545 3/20 0.52
HPGD P15428 2/20 0.52
RECQL P46063 2/20 0.52
HSD17B10 Q99714 2/20 0.52
SMN1; SMN2 Q16637 3/20 0.49
HSD17B2 P37059 1/20 0.49
NPC1 O15118 1/20 0.49
PYGL P06737 2/20 0.48
ALDH1A1 P00352 3/20 0.48
GAA P10253 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8718343 0.88 KMT2A (0.68) KMT2AMEN1RAB9AHTTPOLB
SCHEMBL256788 0.85 KMT2A (0.55) SLC22A6SLC22A8KMT2ARAB9APOLB
SCHEMBL7369097 0.85 SLC22A6 (0.70) SLC22A6SLC22A8KMT2AMEN1RAB9A
SCHEMBL27182902 0.84 SLC22A6 (0.68) SLC22A6SLC22A8KMT2AMEN1RAB9A
SCHEMBL7364817 0.84 SLC22A6 (0.68) SLC22A6SLC22A8KMT2AMEN1RAB9A
SCHEMBL7368597 0.82 SLC22A6 (0.66) SLC22A6SLC22A8KMT2AMEN1RAB9A
SCHEMBL7365546 0.82 SLC22A6 (0.60) SLC22A6SLC22A8KMT2AMEN1RAB9A
SCHEMBL7368576 0.82 SLC22A6 (0.60) SLC22A6SLC22A8KMT2AMEN1RAB9A
SCHEMBL15814046 0.81 SLC22A6 (1.00) SLC22A6SLC22A8KMT2AMEN1RAB9A
SCHEMBL1545793 0.80 SLC22A6 (0.83) SLC22A6SLC22A8KMT2AMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed